Challenging Cases in Breast Cancer - 2021 Annual Meeting

The course has two components. First, the moderator leads a discussion among the panelists of pre-selected difficult cases. These are chosen to highlight current controversies and uncertainties in the modern management of breast cancer, and also to emphasize recent practice-changing clinical trials. In addition to radiation oncologists, the panel includes a breast medical oncologist and breast surgical oncologist to demonstrate the coordinated multidisciplinary collaboration that is essential in modern breast cancer management. The panel also is selected to represent a diversity of radiation oncologists and practice patterns.

Second, the audience had an opportunity to both ask questions about the cases previously presented and also to ask the panel questions about challenging cases or situations they have encountered in their own practice. Questions were asked during the panel, or emailed in advance to the moderator. The amount of time dedicated to each component depended on the total time for the panel, but at least 15 minutes were reserved for audience questions.

This activity is available from January 17, 2022, through 11:59 p.m. Eastern time on January 16, 2025.

This activity was originally recorded at ASTRO’s 2021 Annual Meeting, October 24-27th.

Target Audience

The activity is designed to meet the interests of radiation oncologists, radiation oncology residents, surgeons, nurses and radiation therapists.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Utilize the most modern literature to make the most up to date treatment recommendations for patients with breast cancer.
  • Explain the contribution of a multidisciplinary team to optimize medical decision making in gray-area cases.
Course summary
Available credit: 
  • 1.25 Certificate of Attendance
    This activity was designated for 1.25 AMA PRA Category 1 Credit™.
  • 1.25 SA-CME

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

    The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.25 self-assessment credits.

Course opens: 
01/17/2022
Course expires: 
01/16/2025
Cost:
$105.00
Rating: 
0
  • Julia S. Wong, MD, FASTRO, Dana-Farber Cancer Institute and receives compensation from Oncoclinicas.
  • Rachel Rabinovitch, University of Colorado has no financial relationships with a commercial interest.
  • Julia R. White, MD, FASTRO, The Ohio State University Wexner Medical Center and receives compensation from Exact Science and GHI and Susan G. Komen.
  • Mark Basik, McGill University and and receives compensation from Pfizer Canada.
  • Antonio Wolff, Johns Hopkins University has no financial relationships with a commercial interest.

The person(s) above served as the developer(s) of this activity. Additionally, the Education Committee had control over the content of this activity. All relevant financial relationships have been mitigated.

Disclosure link: 
ASTRO Education Committee

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification. 

Available Credit

  • 1.25 Certificate of Attendance
    This activity was designated for 1.25 AMA PRA Category 1 Credit™.
  • 1.25 SA-CME

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

    The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.25 self-assessment credits.

Price

Cost:
$105.00
Please login or register to take this course.

Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.

Nonmember: $105
Member: $55

If you are an ASTRO member from a low or lower-middle income country, as identified by the World Bank, you can receive a 50% discount off your corresponding registration for this activity. Please email [email protected] to inquire about the discount.

Policies:

No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date.

Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.

The activity and its materials will only be available on the ASTRO website until January 16, 2025, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.